Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.
Karachaliou N, Gonzalez-Cao M, Crespo G, Drozdowskyj A, Aldeguer E, Gimenez-Capitan A, Teixido C, Molina-Vila MA, Viteri S, De Los Llanos Gil M, Algarra SM, Perez-Ruiz E, Marquez-Rodas I, Rodriguez-Abreu D, Blanco R, Puertolas T, Royo MA, Rosell R. Karachaliou N, et al. Among authors: blanco r. Ther Adv Med Oncol. 2018 Jan 18;10:1758834017749748. doi: 10.1177/1758834017749748. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29383037 Free PMC article.
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program.
González-Cao M, Arance A, Piulats JM, Marquez-Rodas I, Manzano JL, Berrocal A, Crespo G, Rodriguez D, Perez-Ruiz E, Berciano M, Soria A, Castano AG, Espinosa E, Montagut C, Alonso L, Puertolas T, Aguado C, Royo MA, Blanco R, Rodríguez JF, Muñoz E, Mut P, Barron F, Martin-Algarra S; Spanish Melanoma Group. González-Cao M, et al. Among authors: blanco r. Clin Transl Oncol. 2017 Jun;19(6):761-768. doi: 10.1007/s12094-016-1602-1. Epub 2017 Jan 4. Clin Transl Oncol. 2017. PMID: 28054320
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial.
Camps C, Massuti B, Jiménez A, Maestu I, Gómez RG, Isla D, González JL, Almenar D, Blasco A, Rosell R, Carrato A, Viñolas N, Batista N, Girón CG, Galán A, López M, Blanco R, Provencio M, Diz P, Felip E; Spanish Lung Cancer Group. Camps C, et al. Among authors: blanco r. Ann Oncol. 2006 Mar;17(3):467-72. doi: 10.1093/annonc/mdj115. Epub 2005 Dec 21. Ann Oncol. 2006. PMID: 16371411 Free article. Clinical Trial.
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.
Provencio M, Serna-Blasco R, Franco F, Calvo V, Royuela A, Auglytė M, Sánchez-Hernández A, de Julián Campayo M, García-Girón C, Dómine M, Blasco A, Sánchez JM, Oramas J, Bosch-Barrera J, Sala MÁ, Sereno M, Ortega AL, Chara L, Hernández B, Padilla A, Coves J, Blanco R, Balsalobre J, Mielgo X, Bueno C, Jantus-Lewintre E, Molina-Vila MÁ, Romero A. Provencio M, et al. Among authors: blanco r. Eur J Cancer. 2021 May;149:61-72. doi: 10.1016/j.ejca.2021.02.031. Epub 2021 Apr 5. Eur J Cancer. 2021. PMID: 33831609 Free article.
Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer.
Provencio M, Camps C, Cobo M, De las Peñas R, Massuti B, Blanco R, Alberola V, Jimenez U, Delgado JR, Cardenal F, Tarón M, Ramírez JL, Sanchez A, Rosell R. Provencio M, et al. Among authors: blanco r. Cancer Chemother Pharmacol. 2012 Dec;70(6):883-90. doi: 10.1007/s00280-012-1985-9. Epub 2012 Sep 29. Cancer Chemother Pharmacol. 2012. PMID: 23053267 Clinical Trial.
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.
Remon J, Isla D, Garrido P, de Castro J, Majem M, Viñolas N, Artal A, Carcereny E, García-Campelo MR, Lianes P, Provencio M, Juan O, Diz P, Blanco R, Lopez-Castro R, Maestu I, Vadell C, Felip E. Remon J, et al. Among authors: blanco r. Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28. Clin Transl Oncol. 2017. PMID: 28660482
Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry.
Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, de Miguel E, Silva-Díaz M, Valero Jaimes JA, González I, Sánchez Martín J, Narváez J, Calvet J, Casafont-Solé I, Román Ivorra JA, Labrada Arrabal S, Vasques Rocha M, Iñiguez CL, Bustabad Reyes MS, Campos Fernández C, Alcalde Villar M, Mas AJ, Blanco R; ARTESER Project Collaborative Group. Molina-Collada J, et al. Among authors: blanco r. Arthritis Res Ther. 2025 Jan 7;27(1):4. doi: 10.1186/s13075-024-03468-6. Arthritis Res Ther. 2025. PMID: 39773317 Free PMC article.
Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry.
Jason MJ, Marzec LN, Piccini JP, Shrader P, Pieper KS, Blanco RG, Fonarow GC, Gersh BJ, Ho PM, Hylek E, Kowey PR, Mahaffey KW, Steinberg BA, Peterson ED, Allen LA. Jason MJ, et al. Among authors: blanco rg. Int J Cardiol. 2025 Feb 15;421:132912. doi: 10.1016/j.ijcard.2024.132912. Epub 2024 Dec 19. Int J Cardiol. 2025. PMID: 39708904
1,200 results